Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 09, 2023 08:00 ET | Source: Alpha Teknova, Inc.

Teknova Announces Opening of New GMP-Certified Facility, Increasing Manufacturing Capacity for Custom, High-Quality Life Sciences Reagents

HOLLISTER, Calif., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, development, and commercialization of...
July 26, 2023 08:00 ET | Source: Alpha Teknova, Inc.

Teknova to Report Second Quarter 2023 Financial Results on August 10, 2023

HOLLISTER, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of...
July 20, 2023 08:00 ET | Source: Alpha Teknova, Inc.

Teknova and Sartorius BIA Separations Share Data Demonstrating Reliable and Scalable Approach for the Enhancement of AAV Full Capsid Enrichment with an Optimized AEX Platform

HOLLISTER, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), and Sartorius BIA Separations, which is part of the international life science group Sartorius,...
July 11, 2023 08:00 ET | Source: Alpha Teknova, Inc.

Teknova Expands Proprietary AAV-Tek™ Solutions Product Line to Deliver End-to-End Solutions for Gene Therapy Process Development

HOLLISTER, Calif., July 11, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and...
May 25, 2023 08:00 ET | Source: Alpha Teknova, Inc.

Teknova to Participate in Upcoming Investor Conference

HOLLISTER, Calif., May 25, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and...
May 10, 2023 16:01 ET | Source: Alpha Teknova, Inc.

Teknova Reports First Quarter 2023 Financial Results

First quarter 2023 total revenue was $9.1 million, up 16% sequentially Launch of proprietary AAV-Tek™ Solutions gene therapy product line Company reaffirms 2023 revenue guidance of $42-46 million ...
May 10, 2023 08:00 ET | Source: Alpha Teknova, Inc.

Teknova to Present Data on Novel Products to Accelerate the Development of AAV Therapies at ASGCT 2023 Annual Meeting

HOLLISTER, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and...
May 04, 2023 08:00 ET | Source: Alpha Teknova, Inc.

Teknova Announces Time Change for First Quarter 2023 Financial Results Conference Call on May 10, 2023

HOLLISTER, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and...
May 02, 2023 08:00 ET | Source: Alpha Teknova, Inc.

Teknova Launches Proprietary AAV-Tek™ Solutions Gene Therapy Product Line to Accelerate the Development of AAV Therapies

HOLLISTER, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and...
April 26, 2023 08:00 ET | Source: Alpha Teknova, Inc.

Teknova to Report First Quarter 2023 Financial Results on May 10, 2023

HOLLISTER, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and...